https://de.marketscreener.com/kurs/aktie/EISAI-CO-LTD-6492461/news/Eisai-Kehrtwende-bei-Alzheimer-Mittel-Biogen-plant-US-Zulassung-29433812/?utm_source=telegram&utm_medium=social&utm_campaign=share